These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30621994)

  • 1. The Authors Reply.
    Sperry BW; Hachamovitch R
    JACC Cardiovasc Imaging; 2019 Jan; 12(1):219. PubMed ID: 30621994
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of positron emission tomography-computed tomography/magnetic resonance imaging in the management of sarcoidosis patients.
    Promteangtrong C; Salavati A; Cheng G; Torigian DA; Alavi A
    Hell J Nucl Med; 2014; 17(2):123-35. PubMed ID: 25097898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in radionuclide imaging of cardiac sarcoidosis.
    Kouranos V; Wells AU; Sharma R; Underwood SR; Wechalekar K
    Br Med Bull; 2015 Sep; 115(1):151-63. PubMed ID: 26311504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging the inflammatory activity of sarcoidosis.
    Keijsers RG; van den Heuvel DA; Grutters JC
    Eur Respir J; 2013 Mar; 41(3):743-51. PubMed ID: 23018903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reply: Using and Interpreting
    Birnie D; Ohira H; Beanlands R
    J Nucl Med; 2017 Dec; 58(12):2040. PubMed ID: 29051345
    [No Abstract]   [Full Text] [Related]  

  • 6. Laryngeal sarcoidosis detected by FDG positron emission tomography.
    Kaira K; Ishizuka T; Yanagitani N; Sunaga N; Hisada T; Mori M
    Clin Nucl Med; 2008 Dec; 33(12):878-9. PubMed ID: 19033796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unusual presentation of sarcoidosis with tetraplegia and severe osteolytic bone lesions.
    Hyldgaard C; Bendstrup E; Hilberg O; Hjorthaug K; Løvgreen M
    Eur Respir J; 2011 Apr; 37(4):964-6. PubMed ID: 21454900
    [No Abstract]   [Full Text] [Related]  

  • 8. The Evaluation of Cardiac Sarcoidosis with 18F-FDG PET.
    Al-Faham Z; Jolepalem P; Oliver Wong CY
    J Nucl Med Technol; 2016 Jun; 44(2):92-3. PubMed ID: 26271805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of Integrated Cardiac Magnetic Resonance/Positron Emission Tomography Imaging as the Preferred Imaging Modality in Cardiac Sarcoidosis.
    Schindler TH
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):108-110. PubMed ID: 28624409
    [No Abstract]   [Full Text] [Related]  

  • 10. Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations.
    Ishida Y; Yoshinaga K; Miyagawa M; Moroi M; Kondoh C; Kiso K; Kumita S
    Ann Nucl Med; 2014 May; 28(4):393-403. PubMed ID: 24464391
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiac magnetic resonance imaging-indeterminate/negative cardiac sarcoidosis revealed by
    Sasson SC; Russo R; Chung T; Chu G; Hunyor I; Williamson J; Murad A; Kane A; Riminton S; Limaye S
    J Med Case Rep; 2017 Oct; 11(1):291. PubMed ID: 29052526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography.
    Tezuka D; Terashima M; Kato Y; Toriihara A; Hirasawa K; Sasaoka T; Yoshikawa S; Maejima Y; Ashikaga T; Suzuki J; Hirao K; Isobe M
    J Card Fail; 2015 Apr; 21(4):313-22. PubMed ID: 25512195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of fluorine-18 fluorodeoxyglucose-positron emission tomography in the diagnosis and therapy of patients with sarcoidosis].
    Li D; Lü PX
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jun; 36(6):447-50. PubMed ID: 24103209
    [No Abstract]   [Full Text] [Related]  

  • 14. Imaging in sinonasal sarcoidosis: CT, MRI, 67Gallium scintigraphy and 18F-FDG PET/CT features.
    Braun JJ; Imperiale A; Riehm S; Veillon F
    J Neuroradiol; 2010 Jul; 37(3):172-81. PubMed ID: 19959235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorodeoxyglucose positron emission tomography for the diagnosis of sarcoidosis in patients with unexplained chronic uveitis.
    Seve P; Billotey C; Janier M; Grange JD; Broussolle C; Kodjikian L
    Ocul Immunol Inflamm; 2009; 17(3):179-84. PubMed ID: 19585360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Impact of FDG-PET/CT Images in Patients With Suspected Cardiac Sarcoidosis: Optimal Patient Preparation, Not Complex Unconventional Analytics, Is Key to Meaningful Data.
    Lu Y; Sweiss NJ; Macapinlac HA
    JACC Cardiovasc Imaging; 2019 Jan; 12(1):217-219. PubMed ID: 30621993
    [No Abstract]   [Full Text] [Related]  

  • 17. Emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: a systematic review.
    Treglia G; Taralli S; Giordano A
    Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):87-94. PubMed ID: 22117499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac Involvement in Sarcoidosis: Evolving Concepts in Diagnosis and Treatment.
    Sayah DM; Bradfield JS; Moriarty JM; Belperio JA; Lynch JP
    Semin Respir Crit Care Med; 2017 Aug; 38(4):477-498. PubMed ID: 28750462
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of [(18)F]fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis and treatment of sarcoidosis in an HIV-2-infected patient.
    Nicolini LA; Taramasso L; Ferrarazzo G; Fiz F; Sambuceti G; Viscoli C; Di Biagio A
    AIDS Res Hum Retroviruses; 2015 Sep; 31(9):868-9. PubMed ID: 25870097
    [No Abstract]   [Full Text] [Related]  

  • 20. Maximizing the Prognostic Value of Cardiac PET in Patients With Suspected Cardiac Sarcoidosis: A Simple Semiquantitative Score May Help.
    Blankstein R; Agarwal V
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):346-348. PubMed ID: 28823739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.